HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DPT-1 Study Group Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

3/2015First test effect in intravenous glucose tolerance testing.
7/2014Distribution of C-peptide and its determinants in North American children at risk for type 1 diabetes.
10/2012Prognostic accuracy of immunologic and metabolic markers for type 1 diabetes in a high-risk population: receiver operating characteristic analysis.
2/2011Islet autoantibody seroconversion in the DPT-1 study: justification for repeat screening throughout childhood.
5/2009Participant and parent experiences in the oral insulin study of the Diabetes Prevention Trial for Type 1 Diabetes.
5/2009Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset.
9/2008Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).
9/2007Participant and parent experiences in the parenteral insulin arm of the diabetes prevention trial for type 1 diabetes.
1/2007Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing.
8/2005Effect of low-dose insulin treatment on body weight and physical development in children and adolescents at risk for type 1 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


DPT-1 Study Group Research Topics

Disease

10Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2015 - 08/2005
2Insulin Resistance
10/2012 - 03/2010
1Body Weight (Weight, Body)
08/2005

Drug/Important Bio-Agent (IBA)

9Insulin (Novolin)FDA Link
03/2015 - 08/2005
4C-PeptideIBA
03/2015 - 03/2010
4Glucose (Dextrose)FDA LinkGeneric
10/2012 - 01/2007
2AutoantibodiesIBA
10/2012 - 02/2011
1Ultralente InsulinFDA Link
08/2005